Compare BLTE & ST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLTE | ST |
|---|---|---|
| Founded | 2018 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.3B |
| IPO Year | 2021 | 2009 |
| Metric | BLTE | ST |
|---|---|---|
| Price | $163.68 | $42.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $228.89 | $53.30 |
| AVG Volume (30 Days) | 168.4K | ★ 1.2M |
| Earning Date | 11-09-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 1.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $3,704,500,000.00 |
| Revenue This Year | N/A | $4.49 |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | ★ N/A | $32.51 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $72.65 | $28.16 |
| 52 Week High | $200.00 | $53.89 |
| Indicator | BLTE | ST |
|---|---|---|
| Relative Strength Index (RSI) | 51.47 | 42.98 |
| Support Level | $167.28 | $40.44 |
| Resistance Level | $172.02 | $43.16 |
| Average True Range (ATR) | 5.28 | 0.86 |
| MACD | -0.86 | 0.07 |
| Stochastic Oscillator | 39.80 | 25.69 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Sensata Technologies is a global supplier of sensors and electrical protection for transportation and industrial applications. Sensata sells a bevy of pressure, temperature, force, and position sensors into the automotive, heavy vehicle, industrial, heating, ventilation, and cooling, and aerospace markets. It also sells electrical protection products, like contactors and relays. The majority of the firm's revenue comes from the automotive market, where it focuses on bumper-in applications.